+
Site Tour

EuroPCR 2023: Improving outcomes in mitral regurgitation

Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.

Related Videos

EuroPCR 2023: Vascular access

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: Defining the future

EuroPCR 2023: COAPT 5-year follow-up

AV VALVES 2023:Decision Making in HF–Tricuspid

Now you've got Navitor.
Stable delivery.

AV VALVES 2023: MR – Mixed MR

Mechanical Heart Valve Patient Story: Sadie

AV VALVES 2023: Trending Topics – Complexity

Navitor™: Voice of the Experts Federico de Marco

TAVI Summit - Cardiac imaging

TRENDING TOPICS

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ Looking ahead

EuroPCR 2022: TAVI 1yr outcomes

Data Summary PFO closure in patients > 60 Years

ESOC presentation: PFO closure in patients > 60 Years

CONNEXT


LIVE
RELATED EVENTS

Case Parade | Tricuspid focus

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

TAVI Summit 2023: Morphology

AV VALVES 2023: Trending Topics – Complexity

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline